Global Wealth Management Investment Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Global Wealth Management Investment Advisory's BIIB Position: Q3 2022 in Review
Global Wealth Management Investment Advisory sold out of Biogen (BIIB) in Q3 2022, closing a stake of 30 shares — an estimated $6K sold.
Global Wealth Management Investment Advisory first reported a position in BIIB in Q4 2018 and held it in 15 quarters. The position peaked at $326K in Q4 2019. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.
- Global Wealth Management Investment Advisory reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
- Global Wealth Management Investment Advisory sold 30 Biogen shares in Q3 2022, an estimated $6K.
- Global Wealth Management Investment Advisory first reported a position in Biogen in Q4 2018 and held it in 15 quarters.
- Global Wealth Management Investment Advisory's Biogen position peaked at $326K in Q4 2019.
- 987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.
Based on Global Wealth Management Investment Advisory's 13F filing for Q3 2022, filed 19 Oct 2022.